Table 4. Multivariate Logistic Regression Analysis on Overall Complications in the Total Cohort.
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p Value | OR | 95% CI | p Value | |
| Age | 1.03 | 1.02–1.03 | <0.001 | 1.02 | 1.01–1.03 | <0.001 |
| Female gender | 1.62 | 1.41–1.87 | <0.001 | 1.45 | 1.23–1.71 | <0.001 |
| BMI | 0.94 | 0.92–0.95 | <0.001 | 0.99 | 0.97–1.01 | 0.247 |
| Previous HF | 1.84 | 1.52–2.21 | <0.001 | 1.52 | 1.22–1.89 | <0.001 |
| PAD | 1.38 | 1.11–1.69 | 0.004 | 1.30 | 1.02–1.64 | 0.036 |
| COPD | 1.67 | 1.21–2.25 | 0.002 | 1.53 | 1.07–2.14 | 0.020 |
| Hemodialysis | 1.74 | 1.34–2.24 | <0.001 | 1.48 | 1.09–1.97 | 0.011 |
| STEMI | 2.64 | 2.32–3.01 | <0.001 | 2.08 | 1.66–2.61 | <0.001 |
| non-STEMI | 1.42 | 1.14–1.74 | 0.002 | 1.45 | 1.09–1.92 | 0.010 |
| Cardiogenic Shock | 9.04 | 7.32–11.17 | <0.001 | 2.39 | 1.84–3.09 | <0.001 |
| IABP use | 9.73 | 8.27–11.45 | <0.001 | 4.90 | 4.02–5.96 | <0.001 |
| Transradial Intervention | 0.39 | 0.33–0.46 | <0.001 | 0.61 | 0.39–0.98 | 0.040 |
| Three-vessel disease | 1.57 | 1.37–1.80 | <0.001 | 1.19 | 1.02–1.39 | 0.024 |
| Type C lesion | 1.74 | 1.53–1.98 | <0.001 | 1.41 | 1.21–1.64 | <0.001 |
| CTO | 1.46 | 1.15–1.82 | 0.002 | 1.42 | 1.08–1.85 | 0.013 |
| Rotablator | 1.95 | 1.50–2.51 | <0.001 | 1.68 | 1.25–2.24 | <0.001 |
OR = odds ratio; CI = confidence interval; BMI = body mass index; HF = heart failure; PAD = peripheral artery disease; COPD = chronic obstructive pulmonary disease; STEMI = ST elevation myocardial infarction; IABP = intra-aortic balloon pumping; CTO = chronic total occlusion.